Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03366506

Investigation of the Epidemiological Factors Associated With the Development of Amyotrophic Lateral Sclerosis (ALS)

Investigation of the epidemiological factors associated with amyotrophic lateral sclerosis (ALS) in Israel with a view to future international collaboration. Particularly addressing:-

1. Differences between ethnic subgroups 2. Differences between immigrant and native-born populations 3. Differences according to military service profile Clinical features gathered at each routine visit ,throughout the entire course of the disease, will be recorded in database format, in order to correlate with potential epidemiological factors.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

ALS

Age range

12 year–120 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hadassah Medical Organisation

Jerusalem, 91120, Israel

Location status: Recruiting

Location contact

Marc Gotkine, MBBS

CONTACT

[email protected]

+972507874692

About this study

Investigation of the epidemiological factors associated with amyotrophic lateral sclerosis (ALS) in Israel with a view to future international collaboration. Particularly addressing:-

  • Differences between ethnic subgroups
  • Differences between immigrant and native-born populations
  • Differences according to military service profile Clinical features gathered at each routine visit ,throughout the entire course of the disease, will be recorded in database format, in order to correlate with potential epidemiological factors.

The clinical features will include pattern of onset, details of full clinical exam ( including ALSFRS-R score, power, reflexes, and other signs of upper or lower-motor neuron dysfunction.

Correlations between different clinical parameters themselves will be made, as well as correlation between clinical parameters and other epidemiological factors.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Suspected, possible, probable ,definite ALS

Exclusion criteria

-

Treatment and study plan

observation

Other

Primary outcomes

  1. Progression rate

    Time frame: up to 10 years

    Progression of ALSFRS-R score over time

Secondary outcomes

  1. Appearance of clinical features of UMN or LMN dysfunction

    Time frame: 10 years

    Appearance of clinical features of UMN or LMN dysfunction over time

Study contacts

Contact information is provided by the study sponsor or research team.

Marc Gotkine, MBBS

CONTACT

[email protected]

+972507874692

Sponsors and collaborators

Lead sponsor

Hadassah Medical Organization

Other

Registry information

Acronym: EpidALS

Important dates

Study start
2009
Primary completion
2049
Study completion
2050
First posted
Dec 8, 2017
Registry last updated
Feb 10, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.